Ravi Ranjan

525 total citations
37 papers, 378 citations indexed

About

Ravi Ranjan is a scholar working on Hematology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ravi Ranjan has authored 37 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 11 papers in Genetics and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ravi Ranjan's work include Blood Coagulation and Thrombosis Mechanisms (15 papers), Hemoglobinopathies and Related Disorders (9 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Ravi Ranjan is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (15 papers), Hemoglobinopathies and Related Disorders (9 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Ravi Ranjan collaborates with scholars based in India, Canada and Saudi Arabia. Ravi Ranjan's co-authors include Renu Saxena, Arijit Biswas, Birendra Kumar Yadav, Madhuri Behari, Mohammad Suhail Akhter, Renu Saxena, Amit Sharma, Tulika Seth, Sanjay Pandey and Parveen Bansal and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Haematology and Clinica Chimica Acta.

In The Last Decade

Ravi Ranjan

36 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ravi Ranjan India 12 222 86 67 57 51 37 378
Petr Ďulíček Czechia 11 123 0.6× 132 1.5× 80 1.2× 63 1.1× 62 1.2× 55 329
Valentina Djordjević Serbia 12 287 1.3× 42 0.5× 195 2.9× 144 2.5× 37 0.7× 47 468
Analía Sánchez‐Luceros Argentina 11 295 1.3× 123 1.4× 53 0.8× 100 1.8× 22 0.4× 34 440
Ferdows Atiq Netherlands 13 247 1.1× 80 0.9× 55 0.8× 77 1.4× 10 0.2× 36 397
Tamara Everington United Kingdom 10 192 0.9× 240 2.8× 103 1.5× 88 1.5× 82 1.6× 23 502
Huub P J Willems Netherlands 5 267 1.2× 154 1.8× 85 1.3× 49 0.9× 279 5.5× 7 529
Sabine Struve Germany 6 378 1.7× 126 1.5× 233 3.5× 200 3.5× 45 0.9× 7 502
Hyoung Soo Choi South Korea 13 204 0.9× 140 1.6× 25 0.4× 53 0.9× 24 0.5× 42 418
Samantha Pasca Italy 13 291 1.3× 73 0.8× 136 2.0× 105 1.8× 9 0.2× 48 486
F. R. Rosendaal Netherlands 9 311 1.4× 58 0.7× 241 3.6× 152 2.7× 15 0.3× 10 447

Countries citing papers authored by Ravi Ranjan

Since Specialization
Citations

This map shows the geographic impact of Ravi Ranjan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Ranjan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Ranjan more than expected).

Fields of papers citing papers by Ravi Ranjan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Ranjan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Ranjan. The network helps show where Ravi Ranjan may publish in the future.

Co-authorship network of co-authors of Ravi Ranjan

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Ranjan. A scholar is included among the top collaborators of Ravi Ranjan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Ranjan. Ravi Ranjan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ranjan, Ravi, Jasmita Dass, Seema Tyagi, et al.. (2023). Prevalence and Impact of HMOX1 Polymorphism (rs2071746: A > T) in Indian Sickle Cell Disease Patients. SHILAP Revista de lepidopterología. 15(4). 583–589. 1 indexed citations
2.
Sagar, Vinay, Ravi Ranjan, Rahul Sharma, et al.. (2021). Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina. Cardiology Research and Practice. 2021. 1–9. 4 indexed citations
3.
Arora, Malika, et al.. (2020). Prevalence of potentially inappropriate medication and its correlates in elderly hospitalized patients: A cross-sectional study based on Beers criteria. Journal of Family and Community Medicine. 27(3). 200–200. 29 indexed citations
4.
5.
Ranjan, Ravi, et al.. (2017). Association of genetic polymorphisms with plasma TFPI level: Boon or curse for DVT patients – Study from India. Blood Cells Molecules and Diseases. 66. 31–36. 2 indexed citations
6.
Sharma, Amit, et al.. (2015). Factors contributing to APC-resistance in women with recurrent spontaneous miscarriages: Indian perspective. Blood Cells Molecules and Diseases. 55(3). 213–215. 2 indexed citations
7.
Sharma, Amit, Ravi Ranjan, Vineet Kumar Kamal, et al.. (2015). Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case–control study in Indian population. Journal of Thrombosis and Thrombolysis. 39(4). 481–488. 8 indexed citations
8.
Sharma, Monica, Sanjay Pandey, Ravi Ranjan, Tulika Seth, & Renu Saxena. (2014). PREVALENCE OF ALPHA THALASSEMIA IN MICROCYTIC ANEMIA: A TERTIARY CARE EXPERIENCE FROM NORTH INDIA. Mediterranean Journal of Hematology and Infectious Diseases. 7(1). e2015004–e2015004. 7 indexed citations
10.
Pandey, Sanjay, et al.. (2012). Phenotypic Heterogeneity of Asian Indian Inversion Deletions Gγ(Aγδβ)0 Breakpoint A and Breakpoint B. Indian Journal of Clinical Biochemistry. 28(1). 98–101. 8 indexed citations
11.
Pandey, Shashank, et al.. (2012). Interaction of - α 3.7, ß Thalassemia Mutation IVS 1-5 and HbD Punjab in a Family: A Case Report. Indian Journal of Clinical Biochemistry. 27(3). 314–317. 1 indexed citations
12.
Biswas, Arijit, et al.. (2010). The nitric oxide synthase 3 gene polymorphisms and their association with deep vein thrombosis in Asian Indian patients. Clinica Chimica Acta. 411(9-10). 649–652. 16 indexed citations
13.
Biswas, Arijit, Ravi Ranjan, Mohammad Suhail Akhter, et al.. (2009). Homocystine Levels, Polymorphisms and the Risk of Ischemic Stroke in Young Asian Indians. Journal of Stroke and Cerebrovascular Diseases. 18(2). 103–110. 35 indexed citations
14.
Biswas, Arijit, Ravi Ranjan, Vinita Sharma, et al.. (2009). Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians. Thrombosis Research. 124(4). 397–402. 14 indexed citations
15.
Biswas, Arijit, Arun K. Tiwari, Ravi Ranjan, et al.. (2008). Prothrombotic polymorphisms, mutations, and their association with pediatric non-cardioembolic stroke in Asian-Indian patients. Annals of Hematology. 88(5). 473–478. 26 indexed citations
16.
Biswas, Arijit, Arun K. Tiwari, Ravi Ranjan, et al.. (2008). Thrombin activatable fibrinolysis inhibitor gene polymorphisms are associated with antigenic levels in the Asian‐Indian population but may not be a risk for stroke. British Journal of Haematology. 143(4). 581–588. 9 indexed citations
17.
Biswas, Arijit, Ravi Ranjan, Noémie Saut, et al.. (2008). TAFI antigen level variability in young healthy Asian Indians; First report from Asia. Clinical Biochemistry. 41(9). 750–753. 1 indexed citations
18.
19.
Ahmad, Firdos, et al.. (2007). Inherited platelet function disorders versus other inherited bleeding disorders: An Indian overview. Thrombosis Research. 121(6). 835–841. 23 indexed citations
20.
Ahmed, Rafeeq, Meganathan Kannan, Arijit Biswas, et al.. (2005). Use of Intron 1 and 22 inversions and linkage analysis in carrier detection of hemophilia A in Indians. Clinica Chimica Acta. 365(1-2). 109–112. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026